A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors

Clinical trial NCT05740956 · RECRUITING

Trial details

NCT number: NCT05740956
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Breast Cancer Pancreatic Cancer Prostatic Cancer Colorectal Cancer

Start date: 2023-06-09
Primary completion: 2026-04-01
Enrollment: 318

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.